Loading...
NPI 1760878995 · Chicago, IL · Hematology & Oncology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Gladys Rodriguez Araiza is a hematology & oncology physician provider located in Chicago, Illinois. This profile covers 22 Medicare and 1 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Gladys Rodriguez Araiza |
| Address | 675 N Saint Clair St Ste 21-100 |
| City | Chicago |
| State | IL |
| ZIP | 60611 |
| Taxonomy | Hematology & Oncology Physician |
| NPI Enumerated | April 14, 2015 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $479.1K |
| Medicaid | $700 |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
22 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 6,480 | $40 | $246.2K |
| J9299 | Injection, nivolumab, 1 mg | 4,200 | $20 | $100.8K |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 1,780 | $40 | $64.1K |
| Q5107 | Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 740 | $20 | $16.3K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 180 | $70 | $12.2K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 90 | $110 | $9.8K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 50 | $150 | $7.5K |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community… | 20 | $210 | $4.9K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 80 | $60 | $4.5K |
| J9041 | Injection, bortezomib, 0.1 mg | 1,190 | $1 | $3.6K |
Showing 1–10 of 22
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 22 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
22 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J9144 | 28 | 50 | 7,740 | $40 | $341.8K |
| J9299 | 30 | 30 | 9,570 | $20 | $305.2K |
| J1569 | 39 | 50 | 2,730 | $40 | $143K |
| Q5107 | 19 | 20 | 1,350 | $20 | $36.3K |
| J2506 | 58 | 70 | 320 | $80 | $32.9K |
| 96413 | 211 | 370 | 130 | $100 | $19.3K |
| G0498 | 64 | 70 | 50 | $200 | $12K |
| 99215 | 2,717 | 6,240 | 40 | $120 | $10.1K |
| 96401 | 90 | 170 | 80 | $60 | $6.8K |
| 96365 | 296 | 410 | 90 | $50 | $6.6K |
Showing 1–10 of 22
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 10 | $50 | $700 |
How this provider's Medicaid billing volume and revenue compare to other Illinois providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Illinois median
1 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 149 | 150 | 170 | $50 | $39.9K |
Other providers in the same ZIP code as Gladys Rodriguez Araiza, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Ann & Robert H. Lurie Children's Hospital Of Chicago | IL | Children's Hospital | $0 | $7.1M |
| Rehabilitation Institute Of Chicago | IL | Rehabilitation Hospital | $0 | $7M |
| Integrated Rehab Consultants LLC | IL | Physical Medicine & Rehabilitation Physician | $0 | $4.3M |
| Sheetal Kircher | IL | Medical Oncology Physician | $1.6M | $6.7K |
| Manjot Gill | IL | Ophthalmology Physician | $1.4M | $240.5K |
| Arthur Mandelin | IL | Rheumatology Physician | $1.2M | $361.3K |
| Jaideep Sohi | IL | Nuclear Radiology Physician | $1.5M | $6.9K |
| Alice Lyon | IL | Ophthalmology Physician | $1.4M | $30K |
| Jessica Altman | IL | Hematology & Oncology Physician | $1.4M | $580 |
| Murad Alam | IL | MOHS-Micrographic Surgery Physician | $1.4M | $11.7K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.